Popular 3D models
No results
About
VIGAFYDE (vigabatrin) oral solution, approved in June 2024, treats infantile spasms in infants aged 1 month to 2 years. This peppermint-flavored 100 mg/mL liquid is weight-based dosed (50–150 mg/kg/day). It carries a risk of irreversible vision loss, requi
Category
Organization / 3D Creation Tool
Website
https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/217684s000lbl.pdf
Member since
July 5th 2025
Stats
0 views
0 likes
0 triangles
0 vertices